SmithRx vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
SmithRx is a San Francisco-based modern PBM founded in 2016 with ~$105M raised; operates on a 100% pass-through model with zero spread pricing; reduces employer drug costs by an average of 30%;
About
SmithRx is a San Francisco-based pharmacy benefits manager (PBM) founded in 2016 by Jake Frenz with a mission to eliminate the opacity, conflicts of interest, and hidden revenue practices that characterize the legacy PBM industry. Operating on a fully transparent, fiduciary-aligned model, SmithRx passes through 100% of rebates and discounts to its employer clients, charges flat administrative fees rather than spread pricing, and provides detailed, auditable reporting on every pharmacy transaction — a stark departure from the "black box" model used by the three dominant PBMs (CVS Caremark, Express Scripts, and OptumRx) that collectively control approximately 80% of the U.S. prescription drug market.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.